California's Cancer Burden
Cancer Disparities: Race/Ethnicity and Sex
Figures 2 and 3: Cancer Disparities
The burden of cancer impacts Californians disproportionately, with the risk of developing cancer varying considerably by race/ethnicity. Among the four major race and ethnic groups, non-Hispanic Whites, both males and females, have the highest incidence of cancer overall, followed by non-Hispanic Blacks, Hispanics, and Asian and Pacific Islanders. Overall, persons of Hispanic and Asian and Pacific Islander and Hispanic origin show cancer incidence rates about 27 to 35 percent lower, respectively, than those of non-Hispanic Whites. Other cancer disparities indicate that the incidence rate for thyroid cancer is 12 percent higher among non-Hispanic White females than among non-Hispanic Black females, while urinary bladder cancer incidence is 20 percent lower among Asian and Pacific Islander males than among non-Hispanic White males. Of the four major race and ethnic groups, non-Hispanic Blacks have the highest cancer mortality among both males and females, followed by non-Hispanic Whites, Hispanics, and Asian and Pacific Islanders. The mortality rate for prostate cancer among non-Hispanic Blacks is 31 percent higher than the rate for Asian and Pacific Islanders (42.8 and 10.1 per 100,000, respectively), while the mortality rate for liver cancer is 12 percent higher among Asian and Pacific Islander males than non-Hispanic White males (12.9 and 7.8 per 100,000, respectively).
(Figures 2 and 3: AAIR and AAMR 2018-2022 by race/ethnicity and sex)
| | Male | | Female | |
| | Rate | Count | Rate | Count |
| Non-Hispanic white | 484.6 | 266,991 | 429.5 | 242,926 |
| Non-Hispanic black | 482.2 | 29,710 | 397.2 | 28,141 |
| Hispanic | 353.4 | 94,780 | 347.4 | 111,284 |
| Asian/Pacific Islander | 300.6 | 51,005 | 332.6 | 68,240 |
*Rates are per 100,000 and age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) standard.
~ Statistic could not be calculated.
^ Statistic not displayed due to fewer than 11 cases.
Source: California Cancer Registry, California Department of Public Health

| | Male | | Female | |
| | Rate | Count | Rate | Count |
| Non-Hispanic white | 166.0 | 90,504 | 123.6 | 79,575 |
| Non-Hispanic black | 202.5 | 10,997 | 148.9 | 10,638 |
| Hispanic | 136.5 | 31,183 | 106.5 | 31,180 |
| Asian/Pacific Islander | 118.7 | 19,398 | 90.8 | 19,392 |
*Rates are per 100,000 and age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) standard.
|
~ Statistic could not be calculated.
|
| ^ Statistic not displayed due to fewer than 11 cases. |
Source: California Cancer Registry, California Department of Public Health
|
Tables 2A-2D show the five leading causes of cancer incidence and mortality among four of California's major racial/ethnic groups by sex. For each of the racial/ethnic groups, prostate cancer is the most commonly diagnosed cancer among males, while breast cancer is the most commonly diagnosed cancer among females. Among both males and females, lung and colorectal cancers rank among the top three most common cancers diagnosed among non-Hispanic Blacks, Hispanics, and Asians and Pacific Islanders, while among non-Hispanic Whites, melanoma of the skin outranks colorectal cancer among the top three most common cancers. Prostate cancer and female breast cancer are the leading causes of cancer-related deaths among non-Hispanic Black and Hispanic groups. Among both males and females, lung cancer is the leading cause of cancer-related death among non-Hispanic Whites and Asian and Pacific Islanders.
All California Males
| Non-Hispanic White
| Non-Hispanic Black
| Hispanic
| Asian/Pacific Islander
|
| | Rate |
| Rate | | Rate | | Rate | | Rate |
| Prostate | 104.3 | Prostate | 108.8
| Prostate | 165.3 | Prostate | 85.9 | Prostate | 60.5 |
| Lung and Bronchus | 40.3 | Melanoma of the Skin | 50.0 | Lung and Bronchus | 57.1 | Colon and Rectum | 37.8 | Lung and Bronchus | 40.7 |
| Colon and Rectum | 38.7 | Lung and Bronchus | 43.9 | Colon and Rectum | 43.2 | Lung and Bronchus | 25.5 | Colon and Rectum | 36.0 |
| Melanoma of the Skin | 30.7 | Colon and Rectum | 38.6 | Kidney and Renal Pelvis | 23.1 | Kidney and Renal Pelvis | 23.6 | Liver and Intrahepatic Bile Duct | 17.6 |
| Urinary Bladder | 27.5 | Urinary Bladder | 35.1 | Urinary Bladder | 20.2 | Non-Hodgkin Lymphoma | 20.4 | Non-Hodgkin Lymphoma | 17.4
|
All California Females
| Non-Hispanic White
| Non-Hispanic Black
| Hispanic
| Asian/Pacific Islander
|
| | Rate | | Rate | | Rate | | Rate | | Rate |
| Breast | 126.6 | Breast | 140.4 | Breast | 128.3 | Breast | 100.0 | Breast | 119.6 |
| Lung and Bronchus | 33.9 | Lung and Bronchus | 39.8 | Lung and Bronchus | 42.5 | Colon and Rectum | 28.5 | Lung and Bronchus | 28.6
|
| Colon and Rectum | 30.7 | Melanoma of the Skin | 31.6 | Colon and Rectum | 34.7 | Corpus and Uterus, NOS | 27.8 | Colon and Rectum | 27.1 |
| Corpus and Uterus, NOS | 28.3 | Colon and Rectum | 31.3 | Corpus and Uterus, NOS | 31.2 | Lung and Bronchus | 20.4 | Corpus and Uterus, NOS | 25.1 |
| Melanoma of the Skin | 18.4 | Corpus and Uterus, NOS | 27.1 | Pancreas | 14.9 | Thyroid | 19.6 | Thyroid | 20.3
|
All California Males
| Non-Hispanic White
| Non-Hispanic Black
| Hispanic
| Asian/Pacific Islander
|
| | Rate | | Rate | | Rate | | Rate | | Rate |
| Lung and Bronchus | 27.4 | Lung and Bronchus | 29.7 | Prostate | 42.8 | Prostate | 18.7 | Lung and Bronchus | 26.5 |
| Prostate | 20.4 | Prostate | 21.7 | Lung and Bronchus | 38.8 | Lung and Bronchus | 18.1 | Liver and Intrahepatic Bile Duct | 12.9 |
| Colon and Rectum | 14.2 | Colon and Rectum | 13.9 | Colon and Rectum | 19.5 | Colon and Rectum | 14.1 | Colon and Rectum | 12.2 |
| Pancreas | 11.8 | Pancreas | 12.6 | Pancreas | 14.4 | Liver and Intrahepatic Bile Duct | 13.9 | Prostate | 10.1 |
| Liver and Intrahepatic Bile Duct | 10.5 | Liver and Intrahepatic Bile Duct | 7.8 | Liver and Intrahepatic Bile Duct | 12.7 | Pancreas | 10.4 | Pancreas | 9.4
|
All California Females
| Non-Hispanic White
| Non-Hispanic Black
| Hispanic
| Asian/Pacific Islander
|
| | Rate | | Rate | | Rate | | Rate | | Rate |
| Lung and Bronchus | 20.2 | Lung and Bronchus | 24.0 | Breast | 28.4 | Breast | 15.2 | Lung and Bronchus | 15.6 |
| Breast | 18.9 | Breast | 20.7 | Lung and Bronchus | 26.2 | Lung and Bronchus | 11.6 | Breast | 13.5 |
| Colon and Rectum | 10.3 | Colon and Rectum | 10.5 | Colon and Rectum | 13.8 | Colon and Rectum | 9.5 | Colon and Rectum | 8.7 |
| Pancreas | 9.3 | Pancreas | 9.3 | Pancreas | 12.4 | Pancreas | 9.1 | Pancreas | 7.9 |
Ovary
| 6.3 | Ovary | 6.9 | Corpus and Uterus, NOS | 10.9 | Liver and Intrahepatic Bile Duct | 7.3 | Liver and Intrahepatic Bile Duct | 5.7
|
Rates are per 100,000 and age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) standard.
Source: California Cancer Registry, California Department of Public Health.
Corpus and Uterus, Not Otherwise Specified